Armistice Capital, LLC 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:03 pm Sale |
2024-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 1,000,000 4.720% |
-1,064,000 (-51.55%) |
Filing |
| 2024-02-14 2:26 pm Sale |
2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 2,064,000 9.800% |
-14,000 (-0.67%) |
Filing |
| 2023-02-14 12:39 pm Purchase |
2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 2,078,000 9.990% |
1,022,000 (+96.78%) |
Filing |
| 2022-02-14 6:31 pm Unchanged |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 1,056,000 5.100% |
0 (Unchanged) |
Filing |
| 2022-02-14 5:14 pm Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 1,056,000 5.100% |
-300,000 (-22.12%) |
Filing |
| 2021-02-16 5:05 pm Purchase |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Armistice Capital, LLC | 1,356,000 6.700% |
1,356,000 (New Position) |
Filing |